Physicians' Education Resource
Last Modified: June 1, 2008
Conference Dates: September 6, 2008
Conference Location: Philadelphia, PA
Sponsoring Group: Physicians' Education Resource
Conference Web Page URL: http://www.cancerconferences.com/gastrointestinal/upper_gi_0908_1102034/index.php
Topics Covered: The Third Symposium on Upper Gastrointestinal Malignancies is designed to update practicing medical, radiation, and surgical oncologists; gastroenterologists; nurses; and other clinicians on the broad advances made in the prevention, early diagnosis, and therapy of upper gastrointestinal malignancies in recent years. This symposium has been designed as an educational and scientific meeting that will provide cutting-edge updates on the biology, diagnosis, and multidisciplinary management of these diseases. Controversies and changes in treatment paradigms for these diseases will be reviewed. Investigational agents and targeted therapies will be discussed, including the context for their potential application in the treatment of upper gastrointestinal malignancies. This interactive symposium will include didactic sessions and case-based discussions with leading faculty that will address the clinical and surgical management of hepatocellular carcinoma, pancreatic cancer, and gastric and esophageal cancers. The afternoon scientific session on “Mouse Models in Oncology” will bring thought leaders together to discuss the impact of animal models on the current research and clinical management of distinct tumor types. This symposium will promote education and collaborative investigation to advance the treatment standards for upper gastrointestinal malignancies within community practice.
Summarize clinical trial data on the surgical and clinical management of hepatocellular carcinoma in the adjuvant and advanced settings Evaluate the impact of targeted therapies on the treatment of hepatocellular carcinoma Discuss current concepts in the biology and pathology of pancreatic cancer Interpret current clinical data on surgical and chemotherapeutic treatment strategies for pancreatic cancer Debate the potential clinical benefit from and impact of antiangiogenic and EGFR-targeted agents on the efficacy of conventional chemotherapy in patients with pancreatic cancer Assess the role of mouse models of GIST, neuroendocrine tumors, and pancreatic and gastric cancers in the research and development of new therapeutic agents in oncology Compare chemotherapeutic approaches to and surgical strategies in the treatment of gastric and esophageal cancer in the adjuvant and neoadjuvant settings Discuss molecular targets for novel agents in the treatment of gastroesophageal cancers and the role of those targets in the disease process.
Who Should Attend: This educational program is directed toward medical, surgical, and radiation oncologists; gastroenterologists; internal medicine and primary care physicians; and fellows interested in hepatocellular, pancreatic, gastric, and esophageal cancers. Nurses, physician assistants, and other individuals interested in the treatment of upper gastrointestinal malignancies are also invited to attend.
Registration Information: Registration fees include continental breakfast, lunch, and syllabus materials. Please complete the registration form and mail it with your payment to the address below, or visit www.CancerConferences.com to register online. Checks and credit cards are accepted. To register by phone or fax, please call (888) 949-0045 or fax (214) 367-3305 (credit cards only). Please make checks payable to Physicians’ Education Resource. A cancellation fee of 25% will be assessed on refunds requested before August 6, 2008, and a 50% fee on refunds requested on August 6, 2008, through August 22, 2008. No refunds will be made after August 22, 2008. There is no charge for substitution. Persons who register within 2 weeks of the meeting might not receive conference materials. Checks and credit cards are accepted. Please make checks payable to Physicians’ Education Resource. * INDUSTRY is defined by PER as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical. Industry registrations cannot be processed online. To request attendance at a meeting, registration can be submitted via fax, phone, or e-mail. For more information, e-mail us at CME@pergrouplp.com.
Conference Fees: Physicians $60.00, Fellows, Nurses, Pharmacists, PAs $40.00, Industry* $250.00
Continuing Education: Yes. Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians’ Education Resource designates this educational activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME. NOTE: Credit designation is accurate at the time of printing.
Feb 25, 2011 - The risk of pulmonary embolism is significantly higher for outpatients with central nervous system, pancreatic, upper gastrointestinal, and lung/pleural malignancies, and lower for hematological and breast malignancies, according to a study published online Feb. 11 in Cancer.
Feb 25, 2011
Jan 20, 2012
Jan 23, 2014
Aug 22, 2014
Nov 26, 2012